Integrating economic analysis into clinical trials

This publication has 7 references indexed in Scilit:

• The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance
  Annals of Internal Medicine, 2005
• Collection of Health-Economic Data Alongside Clinical Trials: Is There a Future for Piggyback Evaluations?
  Value in Health, 2005
• Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle
  BMJ, 2004
• Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes
  Diabetes Care, 2003
• Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program
  Diabetes Care, 2003
• Design Issues for Conducting Cost-Effectiveness Analyses Alongside Clinical Trials
  Annual Review of Public Health, 2001
• Development of WHO guidelines on generalized cost-effectiveness analysis
  Health Economics, 2000